Grants per year
Personal profile
Research Interests
My primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. I am interested in incorporating immunotherapy and molecular testing into clinical trials.
Training Experience
| 2009 | Residency, St. Vincents Hospital, Melbourne Australia |
| 2011 | Residency, University Hospitals Case Medical Center, Cleveland OH |
| 2014 | Fellowship, University of Pittsburgh Medical Center |
| 2014 | Fellowship, Northwestern University |
Education/Academic qualification
MBBS, Flinders University
… → 2005
Research interests
- Cancer Biology
- Colon / Rectal Cancer
- Nanotechnology
- Pancreatic Cancer
Fingerprint
Dive into the research topics where Aparna Kalyan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
Prot #QBGJ398-301: A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PRO
PPD Investigator Services, LLC, QED Therapeutics, Inc.
10/2/20 → 10/2/23
Project: Research project
-
Prot #H3B-6527-G000-101: An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
PPD Investigator Services, LLC, H3 Biomedicine Inc.
2/14/18 → 2/14/21
Project: Research project
-
Prot #D419NC00001: A Phase 1 Study of Durvalumab and IPH2201 in Adult Subjects with Select Advanced Solid Tumors
Carneiro Filho, B. A., Chae, Y. K. & Kalyan, A.
2/6/17 → 2/6/23
Project: Research project
Research Output
-
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
Kamath, S. D., Kalyan, A., Kircher, S., Nimeiri, H., Fought, A. J., Benson, A. & Mulcahy, M., May 1 2020, In: Oncologist. 25, 5, p. e808-e815Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimation
Gabr, A., Ranganathan, S., Mouli, S. K., Riaz, A., Gates, V. L., Kulik, L., Ganger, D., Maddur, H., Moore, C., Hohlastos, E., Katariya, N., Caicedo, J. C., Kalyan, A., Lewandowski, R. J. & Salem, R., Jun 2020, In: Journal of Hepatology. 72, 6, p. 1151-1158 8 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation
Kamath, S. D., Lin, X. & Kalyan, A., Feb 2019, In: Oncologist. 24, 2, p. 151-156 6 p.Research output: Contribution to journal › Article › peer-review
-
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
Kim, S. B., Meric-Bernstam, F., Kalyan, A., Babich, A., Liu, R., Tanigawa, T., Sommer, A., Osada, M., Reetz, F., Laurent, D., Wittemer-Rump, S. & Berlin, J., Oct 1 2019, In: Targeted Oncology. 14, 5, p. 591-601 11 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Piloting a financial counseling intervention for patients with cancer receiving chemotherapy
Kircher, S. M., Yarber, J., Rutsohn, J., Guevara, Y., Lyleroehr, M., Jackson, H. A., Walradt, J., Desai, B., Mulcahy, M., Kalyan, A., Benson, A. B., Agulnik, M., Mohindra, N., DeSouza, J. & Garcia, S. F., Mar 1 2019, In: Journal of oncology practice. 15, 3, p. E202-E210Research output: Contribution to journal › Article › peer-review
3 Scopus citations